Fundraising Fox
Vysioneer
Cambridge, US · Founded 2019 · Delaware corporation · 11 employees on LinkedIn · 1 known investors
Find your way into Vysioneer
Sign up to see every warm intro you have to Vysioneer
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vysioneer team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vysioneer builds AI software that analyzes tumor lesions in medical imaging to assess treatment efficacy, aiming to make oncology clinical trials smaller and faster. It serves cancer researchers and drug developers by extracting all-lesion features and biomarkers that predict treatment outcomes.
Founders & leadership
Vysioneer was founded in 2019 by Jen-Tang Lu.
Investors · 1
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 3 rounds · 2019–2023
▶$750KraisedJun 2023 · 1 investors · Other TechnologyRule 506(b)
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Luke ArmourDirector
- Amount sold
- $750K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedJan 2021 · 5 investors · Other TechnologyRule 506(b)
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $1
- First sale
- Dec 2020
- Incorporated
- Corporation, Massachusetts, 2019
- Federal exemptions
- 06b
▶$500KraisedSep 2019 · 6 investors · Other TechnologyRule 506(b)
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Amount sold
- $500K
- Minimum investment
- $1
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Vysioneer do?
- Vysioneer builds AI software that analyzes tumor lesions in medical imaging to assess treatment efficacy, aiming to make oncology clinical trials smaller and faster. It serves cancer researchers and drug developers by extracting all-lesion features and biomarkers that predict treatment outcomes.
- Who founded Vysioneer?
- Vysioneer was founded by Jen-Tang Lu in 2019.
- Who are Vysioneer's investors?
- Vysioneer's investors include Chaac Ventures.
- How much funding has Vysioneer raised?
- Vysioneer has disclosed $2.8M raised across 3 rounds.
- Where is Vysioneer headquartered?
- Vysioneer is headquartered in Cambridge, US.